The store will not work correctly when cookies are disabled.
US9062043, Table 15, Compound 10
ID: ALA3700565
PubChem CID: 57664083
Max Phase: Preclinical
Molecular Formula: C19H11N3O2S
Molecular Weight: 345.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: C#Cc1cccc(Nc2nc3cc(C(=O)O)ccc3c3scnc23)c1
Standard InChI: InChI=1S/C19H11N3O2S/c1-2-11-4-3-5-13(8-11)21-18-16-17(25-10-20-16)14-7-6-12(19(23)24)9-15(14)22-18/h1,3-10H,(H,21,22)(H,23,24)
Standard InChI Key: VCCRNHDYCAYZQE-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5956 -2.7031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1953 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1932 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4896 -3.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4844 -5.2585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1828 -6.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8863 -5.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8915 -3.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5840 -5.9954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5427 -6.5918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0114 1.7529 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4013 3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9095 2.9665 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
17 19 1 0
19 20 3 0
11 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 7 1 0
25 21 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 345.38 | Molecular Weight (Monoisotopic): 345.0572 | AlogP: 4.27 | #Rotatable Bonds: 3 |
Polar Surface Area: 75.11 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.62 | CX Basic pKa: ┄ | CX LogP: 4.11 | CX LogD: 0.78 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.54 | Np Likeness Score: -1.39 |
References
1. (2015) Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators, |